logo

For the Inventor, By the Inventor

Los Altos, CA, United States of America

John A Edwards

USPTO Granted Patents = 21

Average Co-Inventor Count = 1.8

ph-index = 8

Forward Citations = 170(Granted Patents)


Company Filing History:

goldMedal21 out of 932 
 
Syntex (u.s.a.) Inc.
 patents

Years Active: 1976-1986

Loading Chart...
21 patents (USPTO):Explore Patents
1. 4618696 - 9-oxo-15.alpha.-hydroxy-16-phenoxy and 16-substituted phenoxy (1986-10-21),
2. 4310466 - Thio etianic acid derivatives (1982-01-12),
3. 4263289 - Thio etianic acid derivatives (1981-04-21),
4. 4198404 - 6 Alpha, 6 beta-difluoro-etianic acid derivatives (1980-04-15),
5. 4188385 - Thioetianic acid derivatives (1980-02-12),
6. 4187301 - 17 Beta-thiocarboxylic acid esters of 6 alpha, 6 (1980-02-05),
7. 4178457 - (dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid (1979-12-11),
8. 4089865 - Certain thiazole compounds (1978-05-16),
9. 4080461 - 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives (1978-03-21),
10. 4072696 - 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives (1978-02-07),
11. 4031234 - 1,5(6)-Disubstituted benzimidazole-2-carbamate derivatives having (1977-06-21),
12. 4011320 - 7(8)-Substituted triazinobenzimidazoles and anthelmintic compositions (1977-03-08),
13. 4005202 - 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives (1977-01-25),
14. 4002640 - 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives (1977-01-11),
15. 4001421 - Thiazole cardiovascular agents (1977-01-04),

Title: John A. Edwards: Pioneer in Pharmaceutical Innovations

Introduction: John A. Edwards, based in Los Altos, California, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a remarkable portfolio of 21 patents, Edwards demonstrates a strong commitment to advancing medical science and improving therapeutic options.

Latest Patents: Among his latest patents are compounds that focus on enhancing anti-inflammatory treatments. One notable invention covers a compound with the formula 9-oxo-15.alpha.-hydroxy-16-phenoxy, where variations in the compound's structure offer potential pharmaceutical advantages. Another significant patent involves thio etianic acid derivatives, specifically certain 16.beta.-methyl-3-oxoandrost-4-ene and 16.beta.-methyl-3-oxoandrosta-1,4-diene 17.beta.-thiocarboxylic acid esters. These compounds are designed to be useful as anti-inflammatory steroids, further showcasing Edwards' dedication to impactful innovation in medicine.

Career Highlights: John A. Edwards has spent a considerable portion of his career at Syntex (U.S.A.) Inc., a company known for its groundbreaking work in the pharmaceutical industry. His ability to create and patent innovative compounds has positioned him as a leading inventor in his field, contributing significantly to advancements in drug development and therapeutics.

Collaborations: Throughout his career, Edwards has collaborated with notable professionals, including John H. Fried and Colin C. Beard. These partnerships have likely fostered a rich exchange of ideas and insights, enhancing their collective ability to innovate and push the boundaries of pharmaceutical research.

Conclusion: John A. Edwards stands out as a prominent inventor in the pharmaceutical sector, with a substantial number of patents to his name. His continued efforts in developing novel compounds are paving the way for future advancements in medical treatments, ensuring a lasting impact on healthcare and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…